Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Predicting progression of MGUS/SMM

Niccolò Bolli • 15 Sep 2019
IMW 2019
Multiple Myeloma

Niccolò Bolli, MD, PhD, from the University of Milan, Milan, Italy, talks about predicting the risk of progression from precursor conditions and how they vary from active myeloma. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Niccolò Bolli

2:26
The role of the bone marrow immune microenvironment on response to treatment in multiple myeloma
Niccolò Bolli • 25 Aug 2022
2:52
Genomically aggressive or indolent smoldering myeloma and progression to multiple myeloma
Niccolò Bolli • 25 Sep 2022
2:45
Clinical and genomic diagnosis of smoldering myeloma & identifying patients at risk of progression
Niccolò Bolli • 25 Aug 2022
2:43
Session highlights: clonal hematopoiesis in multiple myeloma
Niccolò Bolli • 25 Aug 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals